Literature DB >> 18484553

Improvement of general symptoms in a chronic psychotic patient treated with finasteride: case report.

D Koethe, M Bortolato, D Piomelli, F M Leweke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18484553     DOI： 10.1055/s-2008-1058110

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN： 0176-3679            Impact factor:   5.788


× No keyword cloud information.
  9 in total

1.  Regional distribution of 5α-reductase type 2 in the adult rat brain: an immunohistochemical analysis.

Authors:  M Paola Castelli; Alberto Casti; Angelo Casu; Roberto Frau; Marco Bortolato; Saturnino Spiga; Maria Grazia Ennas
Journal:  Psychoneuroendocrinology       Date:  2012-07-08       Impact factor: 4.905

2.  Allopregnanolone is required for prepulse inhibition deficits induced by D1 dopamine receptor activation.

Authors:  Laura J Mosher; Roberto Cadeddu; Sabrina Yen; Jeffrey L Staudinger; Francesco Traccis; Stephen C Fowler; Jamie L Maguire; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2019-06-14       Impact factor: 4.905

3.  Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress.

Authors:  Roberto Frau; Federico Abbiati; Valentina Bini; Alberto Casti; Donatella Caruso; Paola Devoto; Marco Bortolato
Journal:  Schizophr Res       Date:  2015-05-18       Impact factor: 4.939

4.  Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice.

Authors:  Roberto Frau; Giuliano Pillolla; Valentina Bini; Simone Tambaro; Paola Devoto; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2012-08-09       Impact factor: 4.905

5.  The Neurosteroidogenic Enzyme 5α-Reductase Mediates Psychotic-Like Complications of Sleep Deprivation.

Authors:  Roberto Frau; Valentina Bini; Alessio Soggiu; Simona Scheggi; Alessandra Pardu; Silvia Fanni; Paola Roncada; Monica Puligheddu; Francesco Marrosu; Donatella Caruso; Paola Devoto; Marco Bortolato
Journal:  Neuropsychopharmacology       Date:  2017-02-15       Impact factor: 7.853

6.  Inhibition of 5α-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation.

Authors:  Paola Devoto; Roberto Frau; Valentina Bini; Giuliano Pillolla; Pierluigi Saba; Giovanna Flore; Marta Corona; Francesco Marrosu; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2011-10-24       Impact factor: 4.905

7.  The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating.

Authors:  Roberto Frau; Laura J Mosher; Valentina Bini; Giuliano Pillolla; Romina Pes; Pierluigi Saba; Silvia Fanni; Paola Devoto; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2015-09-24       Impact factor: 4.905

8.  Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation.

Authors:  Roberto Frau; Valentina Bini; Romina Pes; Giuliano Pillolla; Pierluigi Saba; Paola Devoto; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2013-09-21       Impact factor: 4.905

Review 9.  Neurobehavioural complications of sleep deprivation: Shedding light on the emerging role of neuroactive steroids.

Authors:  Roberto Frau; Francesco Traccis; Marco Bortolato
Journal:  J Neuroendocrinol       Date:  2019-09-30       Impact factor: 3.627
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.